Skip to main content
. 2015 Dec 20;128(24):3276–3282. doi: 10.4103/0366-6999.171357

Table 5.

Clinical characteristics of people with different serum zinc levels

Items Upper tertile Middle tertile Lower tertile Statistic values P
N 137 137 138
Male, n (%) 90 (66) 77 (56) 66 (48) 8.943* 0.011
Age (years), mean ± SD 51 ± 14 57 ± 13 61 ± 12 20.634 <0.001
Waist (cm), mean ± SD 97 ± 11 95 ± 11 95 ± 12 1.631 0.197
BMI (kg/m2), median (range) 26.1 (18.6–43.2) 25.4 (18.1–35.7) 25.4 (17.7–40.0) 5.239* 0.073
Duration (years), median (range) 7 (0–26) 10 (0–31) 13 (0–42) 26.665* <0.001
Prevalence of hypertention, n (%) 67 (48.9) 83 (60.6) 85 (61.6) 5.57* 0.062
HbA1c (%), median (range) 8.3 (5.6–14.7) 8.4 (5.8–13.5) 9.1 (5.8–14.5) 6.784* 0.034
C-P (ng/ml), median (range) 2.14 (0.45–4.79) 1.87 (0.06–17.78) 1.69 (0.11–7.11) 13.984* 0.001
2-h C-P (ng/ml), median (range) 5.10 (0.75–19.98) 4.29 (0.11–18.09) 3.84 (0.60–11.11) 17.565* <0.001
TC (mmol/L), median (range) 4.7 (2.0–12.0) 4.4 (2.5–10.8) 4.3 (2.2–10.0) 6.434* 0.040
TG (mmol/L), median (range) 1.9 (0.6–18.3) 1.6 (0.6–14.9) 1.4 (0.5–10.6) 24.546* <0.001
HDL-C (mmol/L), median (range) 0.9 (0.4–1.9) 1.0 (0.6–1.8) 1.0 (0.4–1.8) 5.424* 0.066
LDL-C (mmol/L), mean ± SD 2.6 ± 0.9 2.6 ± 0.8 2.7 ± 0.9 0.511 0.601
eGFR (ml·min-1·1.73 m-2), mean ± SD 1216 ± 35 114 ± 32 109 ± 34 4.792 0.009
Prevalence of DR, n (%) 14 (10.2) 26 (19.0) 38 (27.5) 13.433* 0.001
Prevalence of DN, n (%) 18 (13.1) 25 (18.2) 48 (34.8) 20.473* <0.001
Prevalence of DPN, n (%) 63 (46.0) 85 (62.0) 86 (62.3) 9.778* 0.008

*χ2 values, F values, Statistical significance. SD: Standard deviation; BMI: Body mass index; HbA1c: Hemoglobin A1c; C-P: C-peptide; TC: Total cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; eGFR: Estimated glomerular filtration rate; DR: Diabetic retinopathy; DN: Diabetic nephropathy; DPN: Diabetic peripheral neuropathy.